Cargando…
Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy
Diseases where fibrosis plays a major role accounts for enormous morbidity and mortality and yet we have very little in our therapeutic arsenal despite decades of research and clinical trials. Our understanding of fibrosis biology is primarily built on data generated in conventional mono-culture or...
Autores principales: | Oakley, Fiona, Gee, Lucy M, Sheerin, Neil S, Borthwick, Lee A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904905/ https://www.ncbi.nlm.nih.gov/pubmed/31731225 http://dx.doi.org/10.1016/j.coph.2019.10.004 |
Ejemplares similares
-
Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy
por: Zhang, Zequn, et al.
Publicado: (2021) -
Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
por: Astor, Todd L., et al.
Publicado: (2023) -
Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017) -
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
por: Khor, Yet H., et al.
Publicado: (2020) -
Fibrotic microtissue array to predict anti-fibrosis drug efficacy
por: Asmani, Mohammadnabi, et al.
Publicado: (2018)